Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review
- PMID: 35741026
- PMCID: PMC9220793
- DOI: 10.3390/cells11121897
Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review
Abstract
COVID-19 infection causes complications, even in people who have had a mild course of the disease. The most dangerous seem to be neurological ailments: anxiety, depression, mixed anxiety-depressive (MAD) syndromes, and irreversible dementia. These conditions can negatively affect the respiratory system, circulatory system, and heart functioning. We believe that phytotherapy can be helpful in all of these conditions. Clinical trials confirm this possibility. The work presents plant materials (Valeriana officinalis, Melissa officinalis, Passiflora incarnata, Piper methysticum, Humulus lupulus, Ballota nigra, Hypericum perforatum, Rhodiola rosea, Lavandula officinalis, Paullinia cupana, Ginkgo biloba, Murraya koenigii, Crataegus monogyna and oxyacantha, Hedera helix, Polygala senega, Pelargonium sidoides, Lichen islandicus, Plantago lanceolata) and their dominant compounds (valeranon, valtrate, apigenin, citronellal, isovitexin, isoorientin, methysticin, humulone, farnesene, acteoside, hypericin, hyperforin, biapigenin, rosavidin, salidroside, linalool acetate, linalool, caffeine, ginkgolide, bilobalide, mihanimbine, epicatechin, hederacoside C,α-hederine, presegenin, umckalin, 6,7,8-trixydroxybenzopyranone disulfate, fumaroprotocetric acid, protolichesteric acid, aucubin, acteoside) responsible for their activity. It also shows the possibility of reducing post-COVID-19 neurological, respiratory, and cardiovascular complications, which can affect the functioning of the nervous system.
Keywords: COVID-19; complications; medicinal herbs; phytotherapy; viral infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.CNS Drugs. 2013 Apr;27(4):301-19. doi: 10.1007/s40263-013-0059-9. CNS Drugs. 2013. PMID: 23653088 Review.
-
Phytotherapy of mood disorders in the light of microbiota-gut-brain axis.Phytomedicine. 2023 Mar;111:154642. doi: 10.1016/j.phymed.2023.154642. Epub 2023 Jan 4. Phytomedicine. 2023. PMID: 36641978 Review.
-
Do recent research studies validate the medicinal plants used in British Columbia, Canada for pet diseases and wild animals taken into temporary care?J Ethnopharmacol. 2019 May 23;236:366-392. doi: 10.1016/j.jep.2019.02.030. Epub 2019 Feb 15. J Ethnopharmacol. 2019. PMID: 30772483 Review.
-
Anti-anxiety Properties of Selected Medicinal Plants.Curr Pharm Biotechnol. 2022;23(8):1041-1060. doi: 10.2174/1389201022666210122125131. Curr Pharm Biotechnol. 2022. PMID: 33480339 Review.
-
Adverse effects of herbal medicines: an overview of systematic reviews.Clin Med (Lond). 2013 Feb;13(1):7-12. doi: 10.7861/clinmedicine.13-1-7. Clin Med (Lond). 2013. PMID: 23472485 Free PMC article. Review.
Cited by
-
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2. NPJ Sci Food. 2024. PMID: 38555403 Free PMC article. Review.
-
Hyperforin modulates MAPK/CCL11 signaling to reduce the inflammatory response of nasal mucosal epithelial cells caused by allergic rhinitis by targeting BCL6.Exp Ther Med. 2023 Oct 27;26(6):579. doi: 10.3892/etm.2023.12278. eCollection 2023 Dec. Exp Ther Med. 2023. PMID: 38023351 Free PMC article.
-
The Role and Mechanism of Hyperoside against Depression-like Behavior in Mice via the NLRP1 Inflammasome.Medicina (Kaunas). 2022 Nov 29;58(12):1749. doi: 10.3390/medicina58121749. Medicina (Kaunas). 2022. PMID: 36556951 Free PMC article.
-
A Randomized Placebo-Controlled Clinical Trial Exploring the Short-Term Cognitive and Cerebrovascular Effects of Consuming Peppermint Tea: A Mediation Study.Hum Psychopharmacol. 2025 May;40(3):e70005. doi: 10.1002/hup.70005. Hum Psychopharmacol. 2025. PMID: 40189738 Free PMC article. Clinical Trial.
-
Acteoside as a multifunctional natural glycoside: therapeutic potential across various diseases.Inflammopharmacology. 2025 Jun 23. doi: 10.1007/s10787-025-01811-0. Online ahead of print. Inflammopharmacology. 2025. PMID: 40549319 Review.
References
-
- Am S., Em A. Medicinal Plants with Antiviral Properties to Tackle COVID-19 Pandemic: A Short-Review. SunText Rev. Biotechnol. 2021;2:122. doi: 10.51737/2766-5097.2021.022. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical